查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511260

到 2030 年雄性脱髮症市场预测：按治疗类型、药物类型、给药管道、通路、最终用户和地区进行的全球分析

Androgenetic Alopecia Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type, Medication Type, Route of Administration, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球男性型脱髮症治疗市场规模将达到 30 亿美元，预计到 2030 年将达到 53 亿美元，预测期内复合年增长率为 9.6%。男性型脱髮症治疗旨在控制由遗传和荷尔蒙因素引起的脱髮，主要影响男性和女性。有几种方法可以促进头髮生长并防止进一步脱髮，包括米诺地尔和Finasteride等药物治疗。头髮移植手术等外科手术也很常见，即将健康的毛囊移植到秃头区域。此外，生活方式的改变，如减轻压力和均衡饮食，可以补充这些治疗方法，并对男性脱髮症提供更全面的效果。

根据《临床与诊断研究杂誌》(JCDR) 的一项研究，大约 60% 的人口患有脱髮，多种因素导致男性和女性脱髮的严重程度。

雄性脱髮症的盛行率不断增加

男性型脱髮症的日益普及对市场产生了重大影响。随着越来越多的人受到这种情况的影响，对有效治疗方法和解决方案的需求不断增加。这一趋势刺激了市场的创新和研究，导致了先进治疗方法和产品的开发，以满足受雄性脱髮症影响的个人的特定需求。市场扩张反映了人们对脱髮管理和恢復的认识和重视程度的提高。

副作用和安全问题

副作用和安全问题是这个市场的主要问题。患者可能会遇到米诺地尔等外用药物的副作用，例如头皮发炎、干燥和髮质改变。Finasteride等内服药物引起了人们对潜在性副作用的担忧。这些挑战凸显了研究和开发更安全、更有效的治疗方法的重要性。

对有效治疗的需求不断增长

市场对有效治疗的需求大幅增加。这是由于意识增强、生活方式改变和人口老化等因素造成的。消费者正在寻求创新的解决方案来有效解决脱髮问题，并且市场快速成长，有机会提供新颖的治疗方法和产品来满足这一需求。

缺乏意识

许多脱髮患者并不完全了解他们管理和治疗脱髮的选择，这可能导致治疗延迟或不足。这种认知的缺乏延伸到了医疗保健提供者，影响了他们为雄性脱髮症患者提供全面指导和支持的能力。该市场的一个主要挑战是公众对可用解决方案及其有效性缺乏认识。

COVID-19 的影响：

COVID-19 的疫情对男性型脱髮症治疗市场产生了重大影响。由于封锁和限制，许多提供脱髮治疗的诊所面临关闭或容量减少，导致患者就诊和治疗程序减少。供应链中断也影响了脱髮治疗和治疗方法的可用性。然而，由于远端医疗咨询的引入以及疫情后医疗服务的逐步恢復，市场正显示出韧性。

毛髮移植领域预计在预测期内规模最大

预计毛髮移植领域在预测期内规模最大。此治疗市场的技术和程序的进步显着改善了治疗结果和患者满意度。由于意识的提高、负担能力的提高以及对更自然外观的渴望等因素，对毛髮移植手术的需求持续增加。随着越来越多的人寻求有效的脱髮解决方案，这一趋势预计将持续下去。

皮肤科诊所预计在预测期内复合年增长率最高

预计皮肤科诊所领域在预测期内的复合年增长率最高。在这些诊所，皮肤科医师进行诊断并开立个人化治疗方案，包括局部和内服药物药物以及 PRP 治疗和植髮等高阶手术。我们还提供全面的咨询和持续监测，以满足每位患者的独特需求，为治疗市场的扩张做出了重大贡献。

比最大的地区

预计北美在预测期内将占据最大的市场占有率。随着患者寻求更有效、侵入性更小的解决方案，头髮再生领域的技术进步（例如雷射治疗设备和干细胞治疗）正在促进市场成长。市场竞争激烈，製药公司、医疗设备製造商和专科诊所透过提供创新产品和服务来争夺市场占有率。

复合年增长率最高的地区：

由于脱髮治疗意识的提高、医疗技术的进步以及可支配收入的增加等因素，预计亚太地区在预测期内将保持最高的复合年增长率。印度、中国和日本等国家对脱髮解决方案（包括药物疗法、治疗方法和手术）的需求激增。市场的主要参与企业正在专注于开发创新产品，以满足不断增长的需求并增加市场影响。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 按产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行概述

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球雄性脱髮症市场：依治疗类型

  • 介绍
  • 局部治疗
  • 口服药物
  • 植髮
  • 低功率雷射治疗 (LLLT)
  • 其他的

第六章全球雄性脱髮症治疗市场：依药物类型

  • 介绍
  • 5-α还原酶抑制剂（5ARI）
  • 米诺地尔
  • Finasteride
  • 度他雄胺
  • 其他的

第七章全球雄性脱髮症治疗市场：依给药途径

  • 介绍
  • 局部解决方案
  • 注射治疗
  • 口服
  • 植入

第八章全球雄性脱髮症市场：按分销管道

  • 介绍
  • 药局
  • 网路零售
  • 专科诊所
  • 医院

第九章全球雄性脱髮症市场：依最终用户分类

  • 介绍
  • 居家医疗
  • 皮肤科诊所
  • 製药
  • 其他的

第十章全球雄性脱髮症市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东/非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Merck & Co., Inc.
  • Johnson & Johnson
  • Pfizer Inc.
  • Bayer AG
  • GlaxoSmithKline
  • Allergan
  • Histogen Inc.
  • Dr. Reddy's Laboratories
  • Cipla Limited
  • Aclaris Therapeutics
  • Anterios, Inc.
  • Aurora Scalp Clinics
  • Shiseido
  • Histogenics Corporation
  • Regenera Activa
  • Sun Pharmaceutical Industries Ltd.
Product Code: SMRC26630

According to Stratistics MRC, the Global Androgenetic Alopecia Treatment Market is accounted for $3.0 billion in 2024 and is expected to reach $5.3 billion by 2030 growing at a CAGR of 9.6% during the forecast period. Androgenetic alopecia treatment aims to manage hair loss caused by genetic and hormonal factors, primarily affecting men and women. It encompasses various approaches, including medications like minoxidil and finasteride, which promote hair growth and prevent further loss. Surgical options like hair transplant surgery are also common, involving the relocation of healthy hair follicles to balding areas. Additionally, lifestyle changes, such as stress reduction and a balanced diet, complement these treatments for more comprehensive results in combating androgenetic alopecia.

According to The Journal of Clinical and Diagnostic Research (JCDR)'s study, roughly 60% of the population suffers from hair loss, with various factors contributing to the severity of pattern hair loss in both sexes.

Market Dynamics:

Driver:

Increasing prevalence of androgenetic alopecia

The increasing prevalence of androgenetic alopecia has significantly impacted the market. As more individuals are affected by this condition, there's a growing demand for effective treatments and solutions. This trend has spurred innovation and research within the market, leading to the development of advanced therapies and products tailored to address the specific needs of individuals experiencing androgenetic alopecia. The market's expansion reflects the rising awareness and emphasis on hair loss management and restoration.

Restraint:

Side effects and safety concerns

In the market, side effects and safety concerns pose significant challenges. Patients may experience adverse reactions such as scalp irritation, dryness, or changes in hair texture with topical medications like minoxidil. Oral medications like finasteride have raised concerns about potential sexual side effects. These challenges underscore the importance of ongoing research and development for safer, more effective treatments.

Opportunity:

Growing demand for effective treatments

The market is experiencing a significant surge in demand for effective treatments. This is driven by factors such as increasing awareness, changing lifestyle patterns, and a growing aging population. Consumers are seeking innovative solutions that can effectively address hair loss concerns, leading to a burgeoning market with opportunities for novel therapies and products to cater to this demand.

Threat:

Lack of awareness

Many individuals affected by this condition may not fully understand the options for managing or treating it, leading to delayed or inadequate treatment. This lack of awareness also extends to healthcare providers, impacting their ability to offer comprehensive guidance and support to patients dealing with androgenetic alopecia. In the market, a significant challenge is the lack of awareness among the general population regarding available solutions and their effectiveness.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the Androgenetic Alopecia Treatment market. Due to lockdowns and restrictions, many clinics offering hair loss treatments faced closures or reduced capacity, leading to a decline in patient visits and treatment procedures. Supply chain disruptions also affected the availability of hair loss medications and therapies. However, the market has shown resilience with the adoption of telemedicine for consultations and the gradual recovery of healthcare services post-pandemic.

The hair transplantation segment is expected to be the largest during the forecast period

The hair transplantation segment is expected to be the largest during the forecast period. In the market for this treatment, advancements in technology and techniques have significantly improved outcomes and patient satisfaction. The demand for hair transplantation procedures continues to rise, driven by factors such as increasing awareness, improved affordability, and the desire for a more natural appearance. This trend is expected to persist as more individuals seek effective solutions for hair loss.

The dermatology clinics segment is expected to have the highest CAGR during the forecast period

The dermatology clinics segment is expected to have the highest CAGR during the forecast period. These clinics employ dermatologists who diagnose and prescribe personalized treatments such as topical medications, oral medications, and advanced procedures like PRP therapy or hair transplants. They also provide comprehensive consultations and ongoing monitoring to address the unique needs of each patient, contributing significantly to the growing market for the treatments.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. Technological advancements in the field of hair restoration, such as laser therapy devices and stem cell treatments, contribute to the growth of the market as patients seek more effective and minimally invasive solutions. The market is competitive, with pharmaceutical companies, medical device manufacturers, and specialized clinics vying for market share by offering innovative products and services.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period driven by factors such as increasing awareness about hair loss treatments, advancements in medical technologies, and rising disposable incomes. Countries like India, China, and Japan are witnessing a surge in demand for hair loss solutions, including medications, therapies, and surgical procedures. Key players in the market are focusing on developing innovative products to cater to this growing demand and enhance their market presence in the region.

Key players in the market

Some of the key players in Androgenetic Alopecia Treatment market include Merck & Co., Inc., Johnson & Johnson, Pfizer Inc., Bayer AG, GlaxoSmithKline, Allergan, Histogen Inc., Dr. Reddy's Laboratories, Cipla Limited, Aclaris Therapeutics, Anterios, Inc., Aurora Scalp Clinics, Shiseido, Histogenics Corporation, Regenera Activa and Sun Pharmaceutical Industries Ltd.

Key Developments:

In December 2023, Sun Pharmaceutical Industries Ltd. entered into a strategic collaboration with Aclaris. Sun Pharma will get exclusive rights for the use of deuruxolitinib JAK inhibitor or other isotopic forms of ruxolitinib used to treat alopecia areata and androgenetic alopecia

In June 2023, Dr. Reddy's Laboratories Ltd. announced an expansion of its generics business in India with the launch of RgenX. This dedicated division offers a wider range of affordable products to patients

In June 2023, Pfizer, Inc. received the U.S. FDA approval of Litfulo (ritlecitinib) to treat hair loss caused by alopecia. The drug blocks inflammatory signals that increase hair loss

Treatment Types Covered:

  • Topical Treatments
  • Oral Medications
  • Hair Transplantation
  • Low-Level Laser Therapy (LLLT)
  • Other Treatment Types

Medication Types Covered:

  • 5-alpha Reductase Inhibitors (5ARIs)
  • Minoxidil
  • Finasteride
  • Dutasteride
  • Other Medication Types

Route of Administrations Covered:

  • Topical Solutions
  • Injectable Treatments
  • Oral
  • Implants

Distribution Channels Covered:

  • Drug Stores
  • Online Retail
  • Specialty Clinics
  • Hospitals

End Users Covered:

  • Homecare Settings
  • Dermatology Clinics
  • Pharmaceutical
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Androgenetic Alopecia Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Topical Treatments
  • 5.3 Oral Medications
  • 5.4 Hair Transplantation
  • 5.5 Low-Level Laser Therapy (LLLT)
  • 5.6 Other Treatment Types

6 Global Androgenetic Alopecia Treatment Market, By Medication Type

  • 6.1 Introduction
  • 6.2 5-alpha Reductase Inhibitors (5ARIs)
  • 6.3 Minoxidil
  • 6.4 Finasteride
  • 6.5 Dutasteride
  • 6.6 Other Medication Types

7 Global Androgenetic Alopecia Treatment Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Topical Solutions
  • 7.3 Injectable Treatments
  • 7.4 Oral
  • 7.5 Implants

8 Global Androgenetic Alopecia Treatment Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Drug Stores
  • 8.3 Online Retail
  • 8.4 Specialty Clinics
  • 8.5 Hospitals

9 Global Androgenetic Alopecia Treatment Market, By End User

  • 9.1 Introduction
  • 9.2 Homecare Settings
  • 9.3 Dermatology Clinics
  • 9.4 Pharmaceutical
  • 9.5 Other End Users

10 Global Androgenetic Alopecia Treatment Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Merck & Co., Inc.
  • 12.2 Johnson & Johnson
  • 12.3 Pfizer Inc.
  • 12.4 Bayer AG
  • 12.5 GlaxoSmithKline
  • 12.6 Allergan
  • 12.7 Histogen Inc.
  • 12.8 Dr. Reddy's Laboratories
  • 12.9 Cipla Limited
  • 12.10 Aclaris Therapeutics
  • 12.11 Anterios, Inc.
  • 12.12 Aurora Scalp Clinics
  • 12.13 Shiseido
  • 12.14 Histogenics Corporation
  • 12.15 Regenera Activa
  • 12.16 Sun Pharmaceutical Industries Ltd.

List of Tables

  • Table 1 Global Androgenetic Alopecia Treatment Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Androgenetic Alopecia Treatment Market Outlook, By Treatment Type (2022-2030) ($MN)
  • Table 3 Global Androgenetic Alopecia Treatment Market Outlook, By Topical Treatments (2022-2030) ($MN)
  • Table 4 Global Androgenetic Alopecia Treatment Market Outlook, By Oral Medications (2022-2030) ($MN)
  • Table 5 Global Androgenetic Alopecia Treatment Market Outlook, By Hair Transplantation (2022-2030) ($MN)
  • Table 6 Global Androgenetic Alopecia Treatment Market Outlook, By Low-Level Laser Therapy (LLLT) (2022-2030) ($MN)
  • Table 7 Global Androgenetic Alopecia Treatment Market Outlook, By Other Treatment Types (2022-2030) ($MN)
  • Table 8 Global Androgenetic Alopecia Treatment Market Outlook, By Medication Type (2022-2030) ($MN)
  • Table 9 Global Androgenetic Alopecia Treatment Market Outlook, By 5-alpha Reductase Inhibitors (5ARIs) (2022-2030) ($MN)
  • Table 10 Global Androgenetic Alopecia Treatment Market Outlook, By Minoxidil (2022-2030) ($MN)
  • Table 11 Global Androgenetic Alopecia Treatment Market Outlook, By Finasteride (2022-2030) ($MN)
  • Table 12 Global Androgenetic Alopecia Treatment Market Outlook, By Dutasteride (2022-2030) ($MN)
  • Table 13 Global Androgenetic Alopecia Treatment Market Outlook, By Other Medication Types (2022-2030) ($MN)
  • Table 14 Global Androgenetic Alopecia Treatment Market Outlook, By Route of Administration (2022-2030) ($MN)
  • Table 15 Global Androgenetic Alopecia Treatment Market Outlook, By Topical Solutions (2022-2030) ($MN)
  • Table 16 Global Androgenetic Alopecia Treatment Market Outlook, By Injectable Treatments (2022-2030) ($MN)
  • Table 17 Global Androgenetic Alopecia Treatment Market Outlook, By Oral (2022-2030) ($MN)
  • Table 18 Global Androgenetic Alopecia Treatment Market Outlook, By Implants (2022-2030) ($MN)
  • Table 19 Global Androgenetic Alopecia Treatment Market Outlook, By Distribution Channel (2022-2030) ($MN)
  • Table 20 Global Androgenetic Alopecia Treatment Market Outlook, By Drug Stores (2022-2030) ($MN)
  • Table 21 Global Androgenetic Alopecia Treatment Market Outlook, By Online Retail (2022-2030) ($MN)
  • Table 22 Global Androgenetic Alopecia Treatment Market Outlook, By Specialty Clinics (2022-2030) ($MN)
  • Table 23 Global Androgenetic Alopecia Treatment Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 24 Global Androgenetic Alopecia Treatment Market Outlook, By End User (2022-2030) ($MN)
  • Table 25 Global Androgenetic Alopecia Treatment Market Outlook, By Homecare Settings (2022-2030) ($MN)
  • Table 26 Global Androgenetic Alopecia Treatment Market Outlook, By Dermatology Clinics (2022-2030) ($MN)
  • Table 27 Global Androgenetic Alopecia Treatment Market Outlook, By Pharmaceutical (2022-2030) ($MN)
  • Table 28 Global Androgenetic Alopecia Treatment Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.